Your browser doesn't support javascript.
loading
Amivantamab plus lazertinib in osimertinib-relapsed EGFR-mutant advanced non-small cell lung cancer: a phase 1 trial.
Cho, Byoung Chul; Kim, Dong-Wan; Spira, Alexander I; Gomez, Jorge E; Haura, Eric B; Kim, Sang-We; Sanborn, Rachel E; Cho, Eun Kyung; Lee, Ki Hyeong; Minchom, Anna; Lee, Jong-Seok; Han, Ji-Youn; Nagasaka, Misako; Sabari, Joshua K; Ou, Sai-Hong Ignatius; Lorenzini, Patricia; Bauml, Joshua M; Curtin, Joshua C; Roshak, Amy; Gao, Grace; Xie, John; Thayu, Meena; Knoblauch, Roland E; Park, Keunchil.
Afiliação
  • Cho BC; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea. CBC1971@yuhs.ac.
  • Kim DW; Seoul National University College of Medicine and Seoul National University Hospital, Seoul, Republic of Korea.
  • Spira AI; Virginia Cancer Specialists Research Institute, US Oncology Research, Fairfax, VA, USA.
  • Gomez JE; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Haura EB; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
  • Kim SW; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Sanborn RE; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA.
  • Cho EK; Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea.
  • Lee KH; Chungbuk National University Hospital, Cheongju, Republic of Korea.
  • Minchom A; Drug Development Unit, Royal Marsden/Institute of Cancer Research, Sutton, UK.
  • Lee JS; Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
  • Han JY; National Cancer Center, Gyeonggi-do, Republic of Korea.
  • Nagasaka M; University of California Irvine School of Medicine, Chao Family Comprehensive Cancer Center, Orange, CA, USA.
  • Sabari JK; New York University School of Medicine, New York, NY, USA.
  • Ou SI; University of California Irvine School of Medicine, Chao Family Comprehensive Cancer Center, Orange, CA, USA.
  • Lorenzini P; Janssen R&D, Spring House, PA, USA.
  • Bauml JM; Janssen R&D, Spring House, PA, USA.
  • Curtin JC; Janssen R&D, Spring House, PA, USA.
  • Roshak A; Janssen R&D, Spring House, PA, USA.
  • Gao G; Janssen R&D, Spring House, PA, USA.
  • Xie J; Janssen R&D, Spring House, PA, USA.
  • Thayu M; Janssen R&D, Spring House, PA, USA.
  • Knoblauch RE; Janssen R&D, Spring House, PA, USA.
  • Park K; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Nat Med ; 29(10): 2577-2585, 2023 10.
Article em En | MEDLINE | ID: mdl-37710001

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article